Attached files
| file | filename |
|---|---|
| 10-Q - QUARTERLY REPORT - Tribute Pharmaceuticals Canada Inc. | tbuff_10q.htm |
| EX-31.2 - CERTIFICATIONS - Tribute Pharmaceuticals Canada Inc. | ex_312.htm |
| EX-32.2 - CERTIFICATIONS - Tribute Pharmaceuticals Canada Inc. | ex_322.htm |
| EX-31.1 - CERTIFICATIONS - Tribute Pharmaceuticals Canada Inc. | ex_311.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Tribute Pharmaceuticals Canada Inc. | Financial_Report.xls |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 (AS ADOPTED
PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002)
I, Rob Harris, Chief Executive Officer, of Tribute Pharmaceuticals Canada Inc. (the "Company"), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
|
|
1.
|
The Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2015 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and,
|
|
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
Date: May 12, 2015
|
By:
|
/s/Rob Harris | |
|
Rob Harris
|
|||
|
President and Chief Executive Officer
|
|||